0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R500 - R1,000 (1)
  • R1,000 - R2,500 (2)
  • -
Status
Brand

Showing 1 - 3 of 3 matches in All Departments

Pandemic Medicine - Why the Global Innovation System Is Broken, and How We Can Fix It (Paperback, New edition): Kathryn C.... Pandemic Medicine - Why the Global Innovation System Is Broken, and How We Can Fix It (Paperback, New edition)
Kathryn C. Ibata-Arens
R748 Discovery Miles 7 480 Ships in 12 - 17 working days

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further ... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private-public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.

Beyond Technonationalism - Biomedical Innovation and Entrepreneurship in Asia (Hardcover): Kathryn C. Ibata-Arens Beyond Technonationalism - Biomedical Innovation and Entrepreneurship in Asia (Hardcover)
Kathryn C. Ibata-Arens
R2,018 Discovery Miles 20 180 Ships in 12 - 17 working days

The biomedical industry, which includes biopharmaceuticals, genomics and stem cell therapies, and medical devices, is among the fastest growing worldwide. While it has been an economic development target of many national governments, Asia is currently on track to reach the epicenter of this growth. What accounts for the rapid and sustained economic growth of biomedicals in Asia? To answer this question, Kathryn Ibata-Arens integrates global and national data with original fieldwork to present a conceptual framework that considers how national governments have managed key factors, like innovative capacity, government policy, and firm-level strategies. Taking China, India, Japan, and Singapore in turn, she compares each country's underlying competitive advantages. What emerges is an argument that countries pursuing networked technonationalism (NTN) effectively upgrade their capacity for innovation and encourage entrepreneurial activity in targeted industries. In contrast to countries that engage in classic technonationalism-like Japan's developmental state approach-networked technonationalists are global minded to outside markets, while remaining nationalistic within the domestic economy. By bringing together aggregate data at the global and national level with original fieldwork and drawing on rich cases, Ibata-Arens telegraphs implications for innovation policy and entrepreneurship strategy in Asia-and beyond.

Pandemic Medicine - Why the Global Innovation System Is Broken, and How We Can Fix It (Hardcover, New edition): Kathryn C.... Pandemic Medicine - Why the Global Innovation System Is Broken, and How We Can Fix It (Hardcover, New edition)
Kathryn C. Ibata-Arens
R2,342 Discovery Miles 23 420 Ships in 12 - 17 working days

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private-public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyses the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Razer Kaira Pro Wireless Gaming…
R3,656 Discovery Miles 36 560
Shield Leather Cream (500ml)
R73 Discovery Miles 730
Sylvanian Families - Walnut Squirrel…
R749 R579 Discovery Miles 5 790
Bestway Dolphin Armbands (23 x 15cm…
R33 R31 Discovery Miles 310
Shield Fresh 24 Gel Air Freshener…
R31 Discovery Miles 310
Patrice Motsepe - An Appetite For…
Janet Smith Paperback R300 R240 Discovery Miles 2 400
World Be Gone
Erasure CD R185 R112 Discovery Miles 1 120
Sony PlayStation Portal Remote Player…
R5,299 Discovery Miles 52 990
Better Choices - Ensuring South Africa's…
Greg Mills, Mcebisi Jonas, … Paperback R350 R301 Discovery Miles 3 010
Loot
Nadine Gordimer Paperback  (2)
R398 R330 Discovery Miles 3 300

 

Partners